Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Justin Haghverdian

Foot and Ankle Surgery Orange, CA Medical Doctor

NPI 1073001962 CMS profile 11305528

101 The City Dr S Bldg 29A, Orange, CA 92868

Open in the dashboard

General payments

$7,722

83 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Justin Haghverdian of Orange, CA is reported in the CMS Open Payments database as having received $7,722 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 47th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,750 20
2024 General $2,806 36
2023 General $1,409 12
2022 General $710 14
2021 General $46 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Justin Haghverdian
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Justin Haghverdian were reported at $2,750. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Justin Haghverdian Foot and Ankle Surgery median Middle half National median
2019 $0 $1,327 $279–$5,421 $163
2020 $0 $795 $121–$3,473 $114
2021 $46 $1,289 $201–$4,963 $132
2022 $710 $1,539 $270–$6,067 $149
2023 $1,409 $1,117 $257–$5,264 $160
2024 $2,806 $1,064 $235–$4,944 $164
2025 $2,750 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $3,372 37 payments
  2. Stryker Corporation $2,521 31 payments
  3. Saxum Surgical, Inc. $1,126 5 payments
  4. MedShape, Inc. $150 1 payment
  5. MIMEDX Group, Inc. $142 1 payment
  6. Exactech, Inc. $129 1 payment
  7. Orthofix Medical, Inc. $102 1 payment
  8. Zimmer Biomet Holdings, Inc. $72 1 payment
  9. Bioventus LLC $43 2 payments
  10. Globus Medical, Inc. $28 1 payment
  11. Other $36 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,971 72 payments
  2. Travel and Lodging $3,751 11 payments
Products named General payments · program years 2021–2025
  1. HOFFMANN $667 13 payments
  2. PROSTEP $568 1 payment
  3. INFINITY ADAPTIS $405 3 payments
  4. AUGMENT INJECTABLE $275 3 payments
  5. VARIAX $274 5 payments
  6. PROPHECY $165 1 payment
  7. DynaNail $150 1 payment
  8. Equinoxe $129 1 payment
  9. VANTAGE $129 1 payment
  10. TRUELOK SYSTEM $102 1 payment
  11. Other $482 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

205

Median for Orthopedic Surgery: 203

Drug cost

$362

Median for Orthopedic Surgery: $1,433

Branded share of claims

7.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 60 $105
Tramadol Hcl Generic 58 $86
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 15 $70
Meloxicam Generic 60 $65
Cephalexin Generic 12 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 96 billing codes

Paid by Medicare

$37,524

Medicare's payments for the services billed

Medicare patients

208

Average age 72

Services billed

451

134 women, 74 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 70%
Diabetes 34%
Chronic kidney disease 26%
Depression 23%
Osteoporosis 22%
Ischemic heart disease 21%
Heart failure 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record